45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Lorna Rodriguez-Rodriguez, MD, PhD

Director of Precision Medicine
Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ
USA 08903

Papers:
71 - Focused Plenary Phase II trial of paclitaxel, 13-cis retinoic acid, and interferon-alfa-2b in the treatment of advanced stage or recurrent cervical cancer